Transplantation, AutologousGraft vs Host DiseaseBlood Transfusion, AutologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningStem Cell TransplantationT-LymphocytesCombined Modality TherapyPeripheral Blood Stem Cell TransplantationTreatment OutcomeWhole-Body IrradiationMelphalanGraft vs Leukemia EffectLymphocyte TransfusionGraft vs Tumor EffectAcute DiseaseCyclophosphamideMultiple MyelomaLymphocyte Culture Test, MixedHistocompatibilityLymphocyte ActivationBone Marrow PurgingCytotoxicity, ImmunologicGraft SurvivalRemission InductionRecurrenceT-Lymphocytes, CytotoxicLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsBusulfanImmunosuppressive AgentsSurvival AnalysisHLA AntigensCarmustineDisease-Free SurvivalLymphocyte DepletionHematopoietic Stem Cell MobilizationTransplantation ChimeraImmunotherapy, AdoptiveSalvage TherapyCD4-Positive T-LymphocytesRetrospective StudiesHodgkin DiseaseAnemia, AplasticTime FactorsMyeloablative AgonistsDendritic CellsAntigens, NeoplasmEtoposideAntigens, CD34ThiotepaCD8-Positive T-LymphocytesCells, CulturedGraft vs Host ReactionSurvival RateChronic DiseaseGranulocyte Colony-Stimulating FactorAntibodies, MonoclonalImmunotherapyCell TransplantationIsoantigensInterleukin-2Leukocyte TransfusionLymphocytesT-Lymphocytes, RegulatoryCancer VaccinesMice, Inbred C57BLAntilymphocyte SerumCell SeparationLeukemia, Myeloid, AcuteHematopoietic Stem CellsCytarabineFollow-Up StudiesTransplantation ImmunologyFlow CytometryLymphomaInterferon-gammaClone Cells